Diagnostics Dialogues - Innovation & Insight
Health & Fitness
Welcome to Diagnostics Dialogues - Innovation & Insight, where we are covering the hottest topics in healthcare with top researchers, doctors, and thought leaders! For this episode, Dr Pat Alagia is joined by Vice President & General Manager of Women’s and Reproductive Health at Quest Diagnostics, Kathleen Valentine, and Quest's Director and Medical Science Liaison for Women’s Health, Dr. Karen Racicot. Together, the group discusses the importance of genetic carrier and prenatal screening, as well as Quest's commitment to health equity and treating women throughout every stage of their lives. This episode is one of our favorites, so get ready for another thoughtful conversation with the brightest minds in healthcare and join us for Diagnostics Dialogues - Innovation & Insight, from Quest Diagnostics.
Follow Us
Presented by Quest Diagnostics
www.questdiagnostics.com
Growing as a Laboratory Partner
Commitment to Employee Health: A Blueprint for Wellness
Exploring Digital Pathology and Artificial Intelligence
Disease Surveillance: Preventing the Next Pandemic
Welcome to Season 2 of Diagnostic Dialogues - Innovation & Insight
Alzheimer’s disease: A new generation of screenings and therapies on the horizon
The successful convergence of clinical and operational thinking in the lab
Achieving the Triple Aim through the power of strong laboratory partnerships
The view from the top: Looking back and ahead in 2022
The power of laboratory analytics
Trends in drug testing resulting from the COVID-19 pandemic
Patient-minded Neurology
Optimize Oncology Care with Clinical Pathways
COVID-19: Supporting Safety for the Front Line
About Diagnostics Dialogues from Quest Diagnostics
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Your Sleep Guru Podcast
Good Nurse Bad Nurse
Nothing much happens: bedtime stories to help you sleep
Huberman Lab